Biotechnology - Biotechnology, Licensing

Filter

Current filters:

BiotechnologyLicensing

Popular Filters

1 to 25 of 415 results

Solasia Pharma and Meiji Seika Pharma collaborate on darinaparsin

19-01-2015

Privately-held Solasia Pharma and fellow Japanese drugmaker Meiji Seika Pharma have entered into a license…

BiotechnologydarinaparsinJapanLicensingMeiji Seika PharmaOncologyResearchSolasia PharmaZiopharm Oncology

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

19-01-2015

UK-based C4X Discovery Holdings has entered into a research agreement with drug discovery alliance Evotec.

BiotechnologyC4X DiscoveryEvotec AGLicensingNeurologicalUK

Cellectis links with Ohio State University on multiple myeloma technology

16-01-2015

France-based genome engineering specialist Cellectis has entered into an exclusive license agreement…

BiotechnologyCD123CD38CellectisCS1LicensingOncologyResearch

AstraZeneca unit in deal with Omnis Pharma for oncolytic viruses in immuno-oncology

15-01-2015

Anglo-Swedish pharma major AstraZeneca’s biologics R&D subsidiary MedImmune has entered into a licensing…

AstraZenecaBiotechnologyLicensingMedImmuneOmnis PharmaceuticalsOncology

Treeway collaborates with uniQure on gene therapy for ALS

15-01-2015

Netherlands-based biotech firm Treeway has entered into a collaboration with Dutch gene therapy company…

BiotechnologyLicensingNeurologicalResearchTreewayuniQure

Celgene exercises option on Agios Pharma’ AG-120

Celgene exercises option on Agios Pharma’ AG-120

14-01-2015

US cancer metabolism specialist Agios Pharmaceuticals says that biotech major Celgene will exercise its…

AG-120Agios PharmaceuticalsBiotechnologyCelgene CorpLicensingOncologyUSA

Mersana Therapeutics in up to $300 million deal with Takeda

13-01-2015

Privately-held US biotech company Mersana Therapeutics has expanded its ongoing collaboration with Japan’s…

BiotechnologyLicensingMersana TherapeuticsOncologyTakeda Pharmaceutical

Vedanta collaborates with Janssen on IBD drug candidate VE202

13-01-2015

US microbiome company Vedanta Biosciences has signed a license agreement with Janssen Biotech for Vedanta's…

BiotechnologyGastro-intestinalsJanssen BiotechJohnson & JohnsonLicensingResearchVE202Vedanta Biosciences

AC Immune out-licenses anti-Tau vaccine to Janssen in up to $509 million deal

12-01-2015

Switzerland’s biopharma company AC Immune has entered into a worldwide exclusive license agreement…

AC ImmuneBiotechnologyGlobalJanssen Research & DevelopmentJohnson & JohnsonLicensingNeurological

Egalet buys in two innovative approved pain products, Oxaydo and Sprix

09-01-2015

US biotech firm Egalet Corp has in-licensing two innovative approved pain products transforming Egalet…

Acura PharmaceuticalsBiotechnologyDaiichi SankyoEgalet CorpGlobalLicensingLuitpold PharmaNeurologicalOxaydoSPRIX

Biotech industry shatters key fundraising records in 2014

08-01-2015

The biotech industry shattered records for venture investment, IPOs (initial public offerings) and M&A…

BiotechnologyFinancialGlobalLicensing

Cytos out-licenses VLP platform for hep B infections to OnCore Biopharma

06-01-2015

Switzerland-based Cytos Biotechnology has executed an exclusive license agreement granting privately-held…

Anti-viralsBiotechnologyCytos BiotechnologyLicensingOnCore BioPharma

Vectura links with Janssen on asthma/COPD drug development

Vectura links with Janssen on asthma/COPD drug development

06-01-2015

UK inhaled therapies developer Vectura Group has entered into a global development and licence agreement…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingResearchRespiratory and PulmonaryVectura

Isis Pharma teams up with Janssen on autoimmune disorders in the GI tract

05-01-2015

Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech, a unit of US health…

BiotechnologyGastro-intestinalsIsis PharmaceuticalsJanssen BiotechJohnson & JohnsonLicensingResearch

Amgen and Kite Pharma collaborate on CAR T cell therapies

05-01-2015

Kite Pharma has announced a strategic research collaboration and license agreement with US biotech giant…

AmgenBiotechnologyKite PharmaLicensingOncologyResearch

TxCell and Ferring collaborate with Trizell on lead product Ovasave

TxCell and Ferring collaborate with Trizell on lead product Ovasave

04-01-2015

French biotech firm TxCell on Friday announced a further enhancement to the development of its lead product…

BiotechnologyFerring PharmaceuticalsGastro-intestinalsLicensingOvaSaveResearchTrizell HoldingTxCell

Tikcro to fund cancer immune checkpoint antibodies research at Weizmann

31-12-2014

Israel’s Tikcro Technologies has entered into a research and license accord with Yeda Research and…

BiotechnologyIsraelLicensingOncologyResearchTikcro TechnologiesYeda Research and Development

Roivant acquires GSK's Alzheimer's drug

Roivant acquires GSK's Alzheimer's drug

29-12-2014

Bermuda-based biotech firm Roivant Neurosciences, wholly-owned subsidiary of Roivant Sciences, has entered…

BiotechnologyGlaxoSmithKlineLicensingNeurologicalRoivant

Astellas and Cytokinetics expand accord on skeletal muscle activators

Astellas and Cytokinetics expand accord on skeletal muscle activators

26-12-2014

US biotech firm Cytokinetics and Japanese pharma major Astellas Pharma have amended their collaboration…

Astellas PharmaBiotechnologyCK-2127107CytokineticsLicensingResearch

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

24-12-2014

US specialty pharma firm Ariad Pharmaceuticals has entered into an agreement for Japan’s Otsuka Pharmaceuticals…

Ariad PharmaceuticalsAsia-PacificBiotechnologyIclusigJapanLicensingOncologyOtsuka PharmaceuticalResearch

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

EpiVax links with Novozymes Biopharma to advance autoimmune diseases treatment

23-12-2014

Danish drugmaker Novozymes’ Veltis albumin-based half-life extension platform will help move Tregitope…

BiotechnologyImmunologicalsLicensingNovozymesResearchTregitopeVeltis

Sevion in antibody discovery accord with Johnson & Johnson Innovation and Janssen

22-12-2014

USA-based biopharma firm Sevion Therapeutics has entered into a collaboration agreement with CNA Development,…

BiotechnologyJanssenJohnson & JohnsonLicensingResearchSevion Therapeutics

Tiziana licenses anti-inflammatory foralumab from Novimmune

Tiziana licenses anti-inflammatory foralumab from Novimmune

22-12-2014

Oncology and immunology specialist Tiziana and antibody-based drug manufacturer Novimmune have entered…

BiotechnologyImmunologicalsLicensingNovImmuneTiziana

1 to 25 of 415 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top